Dominic Walsh
Affiliations: | Neurology | Harvard Medical School - Brigham and Women's Hospital |
Google:
"Dominic Walsh"Mean distance: (not calculated yet)
Parents
Sign in to add mentorChildren
Sign in to add trainee| Wei Hong | grad student | ||
| Zhicheng Chen | post-doc | Harvard Medical School - Brigham and Women's Hospital |
Collaborators
Sign in to add collaborator| Kyongman AN | collaborator | 2012-2014 | Harvard Medical School - Brigham and Women's Hospital |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Purro SA, Farmer M, Noble E, et al. (2023) Two mouse models of Alzheimer's disease accumulate amyloid at different rates and have distinct Aβ oligomer profiles unaltered by ablation of cellular prion protein. Plos One. 18: e0294465 |
| Ondrejcak T, Klyubin I, Hu NW, et al. (2023) Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation . The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 43: 5870-5879 |
| Wang Z, Jin M, Hong W, et al. (2023) Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer's disease immunotherapeutics. Acta Neuropathologica Communications. 11: 39 |
| Hong W, Liu W, Desousa AO, et al. (2023) Methods for the isolation and analysis of Aβ from postmortem brain. Frontiers in Neuroscience. 17: 1108715 |
| Mengel D, Mok TH, Nihat A, et al. (2021) NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression. Cells. 10 |
| Podracky CJ, An C, DeSousa A, et al. (2021) Laboratory evolution of a sortase enzyme that modifies amyloid-β protein. Nature Chemical Biology |
| Mengel D, Janelidze S, Glynn RJ, et al. (2020) Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease. Annals of Neurology |
| Walsh DM, Selkoe DJ. (2020) Amyloid β-protein and beyond: the path forward in Alzheimer's disease. Current Opinion in Neurobiology. 61: 116-124 |
| Mengel D, Liu W, Glynn RJ, et al. (2020) Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase. Alzheimer's Research & Therapy. 12: 27 |
| Corbett GT, Wang Z, Hong W, et al. (2019) PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathologica |